A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

Conditions: Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Interventions: Drug: LY3650150; Drug: Placebo; Drug: Standard therapy for INCS Sponsors: Eli Lilly and Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials